Trial intelligence / Profile preview

Lutikizumab in Knee Osteoarthritis

NCT02087904Phase 2Completed

Sponsor
AbbVie Inc.
Start
Jun 2014
Primary completion
Jun 2016
01

Overview

A Phase 2 trial of lutikizumab in osteoarthritis (OA), sponsored by AbbVie Inc.. Started Jun 2014; status: completed.

02

Drugs

lutikizumab
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02087904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02087904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call